1. Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Schonhoff S, Baggio L, Ratineau C, Ray SK, Lindner J, Magnuson MA, Drucker DJ, Leiter AB (2005) Mol Cell Biol 25(10): 4189-99
    › Primary publication · 15870288 (PubMed) · PMC1087718 (PubMed Central)
  2. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA (2005) Proc Natl Acad Sci U S A 102(17): 6207-12
    › Primary publication · 15833818 (PubMed) · PMC556131 (PubMed Central)
  3. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, Linton MF (2005) Arterioscler Thromb Vasc Biol 25(8): 1647-53
    › Primary publication · 15947238 (PubMed)
  4. 5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Wang CZ, Wang Y, Di A, Magnuson MA, Ye H, Roe MW, Nelson DJ, Bell GI, Philipson LH (2005) Biochem Biophys Res Commun 330(4): 1073-9
    › Primary publication · 15823553 (PubMed)
  5. The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised. Moates JM, Magnuson MA (2004) Diabetologia 47(9): 1632-40
    › Primary publication · 15365616 (PubMed)
  6. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. Doliba NM, Qin W, Vatamaniuk MZ, Li C, Zelent D, Najafi H, Buettger CW, Collins HW, Carr RD, Magnuson MA, Matschinsky FM (2004) Am J Physiol Endocrinol Metab 286(5): E834-43
    › Primary publication · 14736703 (PubMed)
  7. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats. Chu CA, Fujimoto Y, Igawa K, Grimsby J, Grippo JF, Magnuson MA, Cherrington AD, Shiota M (2004) Am J Physiol Gastrointest Liver Physiol 286(4): G627-34
    › Primary publication · 14656711 (PubMed)
  8. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA, Wu H (2004) Proc Natl Acad Sci U S A 101(7): 2082-7
    › Primary publication · 14769918 (PubMed) · PMC357055 (PubMed Central)
  9. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Gorogawa S, Fujitani Y, Kaneto H, Hazama Y, Watada H, Miyamoto Y, Takeda K, Akira S, Magnuson MA, Yamasaki Y, Kajimoto Y, Hori M (2004) Biochem Biophys Res Commun 319(4): 1159-70
    › Primary publication · 15194489 (PubMed)
  10. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. Burgess SC, Hausler N, Merritt M, Jeffrey FM, Storey C, Milde A, Koshy S, Lindner J, Magnuson MA, Malloy CR, Sherry AD (2004) J Biol Chem 279(47): 48941-9
    › Primary publication · 15347677 (PubMed)